Interestingly, upregulation of CD200, CD99 and PECAM1 in the FA predicted AML cells, in comparison to Healthy or FA non_AML cells (Fig 4A), opens the possibility to discover novel AML-associated markers, especially in the FA context. This evidence concerns the gene PECAM1 and acute myeloid leukemia.